BioGaia's Annual and Sustainability Report 2022 and the Remuneration Report 2022 can be downloaded here: https://www.biogaia.com/investors/annual-reports/.
The Swedish Annual and Sustainability Report 2022 is also available on BioGaia's website in European Single Electronic Format (ESEF).
BioGaia's Corporate Governance Report 2022 can be downloaded here: https://www.biogaia.com/investors/corporate-governance-report/
Subscribe to BioGaia press releases here (https://www.biogaia.com/press/subscribe-to-press-releases/)
LinkedIn here (https://www.linkedin.com/company/biogaia-ab/)
Alexander Kotsinas, CFO
Phone: +46 735 00 11 11
Mikaela Idermark Stern, Corporate Communications
Phone: +46 730 95 61 50
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through distribution partners or through our own distribution in more than 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaia.com (https://www.biogaia.com/)
This disclosure contains information that BioGaia is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication at 11:00 AM CEST on March 27, 2023.